Chinese Journal of Tissue Engineering Research ›› 2025, Vol. 29 ›› Issue (20): 4333-4340.doi: 10.12307/2025.711

Previous Articles     Next Articles

Traditional Chinese medicine monomers regulate ferroptosis to combat myocardial ischemia-reperfusion injury

Shen Xiaoqiu1, Wang Zhentao2, Qiu Yueqing1, Song Chenghao1   

  1. 1The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, Henan Province, China; 2Henan Provincial Hospital of Traditional Chinese Medicine, Zhengzhou 450002, Henan Province, China
  • Received:2024-07-11 Accepted:2024-09-24 Online:2025-07-18 Published:2024-12-23
  • Contact: Wang Zhentao, Doctoral supervisor, Professor, Chief physician, Henan Provincial Hospital of Traditional Chinese Medicine, Zhengzhou 450002, Henan Province, China
  • About author:Shen Xiaoqiu, MS, The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou 450002, Henan Province, China
  • Supported by:
     the National Natural Science Foundation of China, No. 81573920 (to WZT)

Abstract: BACKGROUND: Ferroptosis is a programmed cell death caused by iron dependent lipid peroxidation, involving various processes such as iron overload, lipid peroxidation, and endoplasmic reticulum stress. Research has found that ferroptosis is closely related to the occurrence and development of myocardial ischemia-reperfusion injury, and has become a new target and perspective for MIRI treatment. Traditional Chinese medicine has advantages such as multi-target, multi-level, and fewer adverse reactions, and has significant effects in the treatment of myocardial ischemia-reperfusion injury, with a far-reaching impact. 
OBJECTIVE: Taking ferroptosis as the starting point, to systematically elaborate and summarize the research progress in the modulation of ferroptosis against myocardial ischemia-reperfusion injury by monomers of traditional Chinese medicines such as puerarin, resveratrol, ligustrazine, and astragaloside IV in recent years. 
METHODS: Using the search terms “iron death, myocardial injury, myocardial ischemia-reperfusion injury, signaling pathways, traditional Chinese medicine monomers, flavonoids, polyphenols, alkaloids, terpenes, quinones” in Chinese and English from January 2013 to June 2024, literature retrieval was performed in the CNKI and PubMed respectively for literature related to ferroptosis, myocardial ischemia-reperfusion injury, and the regulatory mechanism of traditional Chinese medicine monomers. Literature that is not highly correlated, repetitive, or outdated was excluded. A total of 1 524 relevant articles were retrieved, and 76 articles were ultimately included for review. 
RESULTS AND CONCLUSION: Numerous animal and cell experiments have shown that ferroptosis plays an important role in the occurrence and progression of myocardial ischemia-reperfusion injury. Traditional Chinese medicine monomers such as baicalin, resveratrol, and ligustrazine can regulate iron metabolism, reduce iron deposition, and inhibit ferroptosis in myocardial cells. Pectin, quercetin, and salidroside can improve mitochondrial function, enhance cellular antioxidant capacity, and alleviate myocardial ischemia-reperfusion injury. Traditional Chinese medicine monomers can regulate ferroptosis-related signaling pathways, such as solute carrier family 7 member 11/glutathione peroxidase 4, dihydrolactate dehydrogenase/coenzyme Q10, cyclooxygenase 2/prostaglandin E2, and adenosine monophosphate-activated protein kinase, resist myocardial ischemia-reperfusion injury, and reduce ferroptosis in myocardial cells.

中国组织工程研究杂志出版内容重点:组织构建;骨细胞;软骨细胞;细胞培养;成纤维细胞;血管内皮细胞;骨质疏松;组织工程

Key words: ferroptosis, myocardial ischemia-reperfusion injury, signaling pathway, traditional Chinese medicine monomers, mechanism of action, engineered tissue construction

CLC Number: